To evaluate the clinical impact of a comprehensive medication management (CMM) service in a Brazilian primary health-care setting.
Methods:
A quasi-experimental study has been carried out between July 2014 and November 2016 with patients who received the service in the primary care setting of a Brazilian city (n = 1057). Factors associated with drug therapy problems (DTP) detection in the initial assessment were evaluated by performing univariate and multivariate analyzes. To evaluate the impact of the CMM service, a linear regression model was constructed from the difference between the initial and final values of the clinical and laboratory parameters adjusted by multiple variables.
Results:
A total of 1642 DTPs was identified, the most prevalent one being “nonadherence” (31.9%) and the “need for additional drug therapy” (22.9%). The use of 5 or more medications and the presence of 3 or more diseases were positively associated with the identification of 3 or more DTPs during the initial assessment. Even after multiple adjustments, a statistically significant reduction has been observed in the values of glycated hemoglobin, systolic blood pressure, low-density cholesterol, and total cholesterol.
Conclusion:
The CMM service contributed to the resolution of DTP and showed positive clinical impact in primary health care in the studied setting.
Instituto Brasileiro de Geografia e Estatística. Pesquisa nacional de saúde: percepção do estado de saúde, estilos de vida e doenças crônicas. 2013. Accessed September 11, 2018. http://ftp.ibge.gov.br/PNS/2013/pns2013.pdf.
3.
NascimentoRCRÁlvaresJGuerra JúniorAA, et al.Polypharmacy: a challenge for primary health care of Brazilian Unified Health System. Rev Saude Publica. 2017;51(suppl 2):19s.
4.
HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–543.
CipolleRJStrandLMMorleyPC. Pharmaceutical Care Practice: The Clinician’s Guide. New York, NY: McGraw-Hill Medical; 2004:624.
7.
Ramalho de OliveiraD. The Reality of Pharmaceutical Care-Based Medication Therapy Management: Patients’, Pharmacists’ and Students’ Perspectives. New York, NY: LAP Lambert Academic; 2009:400.
8.
WatanabeJHMcInnisTHirschJD. Cost of prescription drug–related morbidity and mortality. Ann Pharmacother. 2018;52(9):829–837.
9.
CipolleRJStrandLMMorleyPC. Pharmaceutical Care Practice. New York, NY: McGraw-Hill; 1998:359.
10.
CipolleRJStrandLMMorleyPC. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services. New York, NY: McGraw-Hill; 2012:697.
11.
WiedenmayerKSummersRSMackieCA, et al.Developing pharmacy practice: a focus on patient care. 2006. Accessed September 11, 2018. http://www.who.int/iris/handle/10665/69399.
12.
BrummelARSolimanAMCarlsonAMde OliveiraDR. Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag. 2013;16(1):28–34.
13.
DetoniKBOliveiraIVNascimentoMMGCauxTRAlvesMRRamalho-de-OliveiraD. Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease. Int J Clin Pharm. 2017;39(1):95–103.
14.
I IsettsBJSchondelmeyerSWArtzMB, et al.Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48(2):203–211.
15.
MendonçaSAMMeloACPereiraGCC, et al.Clinical outcomes of medication therapy management services in primary health care. Braz J Pharm Sci. 2016;52(3):365–373.
16.
Ramalho de OliveiraDBrummelARMillerDB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16(3):185–195.
17.
Obreli-NetoPRMarusicSGuidoniCM, et al.Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial. J Manag Care Spec Pharm. 2015;21(1):66–75.
18.
BorgesAPSGuidoniCMFreitasO, et al.Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. Arq Bras Endocrinol Metabol. 2011;55(9):686–691.
19.
OliveiraGEAlvesMRRamalho de OliveiraD. Action research as a tool for transformation of the pharmacist’ s praxis in primary care. Int J Pharm Pharm Sci. 2017;9(3):180–185.
MourãoAOMFerreiraWRMartinsMAP, et al.Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm. 2013;35(1):79–86.
22.
StrandLMCipolleRJMorleyPC, et al.The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr Pharm Des. 2004;10(31):3987–4001.
23.
SouzaIGNascimentoMMGNevesCM, et al.Clinical results of a comprehensive medication management program in a diabetes ambulatory clinic. Rev Bras Farm Hosp Serv Saude. 2017;8(3):19–24.
24.
CastelliGBacciJLDombrowskiSK, et al.Pharmacist-delivered comprehensive medication management within family medicine practices. Fam Med. 2018;50(8):605–612.
25.
ViswanathanMGolinCEJonesCD, et al.Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795.
RaoDGilbertAStrandLM, et al.Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29(6):647–654.
28.
SorensenTDPestkaDLBrummerAR, et al.Seeing the forest through the trees: improving adherence alone will not optimize medication use. Pharm J Manag Care Spec Pharm. 2016;22(5):599–604.
29.
SilvaDAMMendonçaSAMO´DoughertyM, et al.Autoethnography as an instrument for professional (trans) formation in pharmaceutical care practice. Qual Rep. 2017;22(5):2926–2942.
30.
ViswanathanMKahwatiLCGolinCE, et al.Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(1):76–87.
31.
HirschJDSteersNAdlerDS, et al.Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9):1244–1254.
32.
BuntingBASmithBHSutherlandSE. The Asheville project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48(1):23–31.
33.
PlanasLGCrosbyKMMitchellKDFarmerKC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49(2):164–170.
34.
CliffordRMDavisWABattyKTDavisTM; Fremantle Diabetes Study. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle diabetes study. Diabetes Care. 2005;28(4):771–776.
35.
Ramalho de OliveiraD. Pharmaceutical Care: From Its Philosophy to Comprehensive Medication Management Services. São Paulo, Brazil: RCN Editora; 2011:328.
